Author | Mark G. Kris, MD | OncLive

Author | Mark G. Kris, MD

Articles

Dr. Kris on Search for Biomarkers in Advanced Squamous NSCLC

November 13, 2019

Video

Mark G. Kris, MD, discusses the ongoing search for additional biomarkers in advanced squamous non­–small cell lung cancer.

Dr. Kris on the Impact of Bevacizumab Biosimilars in Lung Cancer

October 23, 2019

Video

Mark G. Kris, MD, discusses the impact biosimilars for bevacizumab (Avastin) could have in lung cancer.

Dr. Kris on the RELAY Trial in EGFR+ NSCLC

August 30, 2019

Video

Mark G. Kris, MD, discusses the RELAY trial, which was an international, double-blind, randomized phase III study examining erlotinib in combination with ramucirumab versus placebo in previously untreated patients with EGFR-mutant metastatic non-small cell lung cancer.

Dr. Kris on Predicting Benefit With Osimertinib in EGFR+ NSCLC

June 13, 2019

Video

Mark G. Kris, MD, medical oncologist, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, discusses methods for predicting benefit with osimertinib (Tagrisso) in patients with EGFR-positive non–small cell lung cancer (NSCLC).

x